5Sp iegelm an BM. PPA R - gamm a : adipogen ic regu la r andth iazo - lidinedione recep to r. Diabetes 1998 ;47:507 - 514.
二级参考文献5
1Lindholm A,Jacobsen LV.Clinical pharmacokinetics and pharmacodynamics of insulin aspart.Clin Pharmacokinet,2001,40(9):641-659
2Homko C,Deluzio A,Jimenez C,et al.Comparison of insulin aspart and lispro:pharmacokinetic and metabolic effects.Diabetes Care,2003,26(7):2027-2031
3Kahn SE,Montgomery B,Howell W,et al.Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus.J Clin Endocrinol Metab,2001,86:5824-5829
4Reynolds NA,Wagstaff AJ.Insulin aspart:a review of its use in the management of type 1 or 2 diabetes mellitus.Drugs,2004,64(17):1957-1974
5Thomas D,Jan A,Edith S,et al.A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes.Diabetes Care,2003,26(8):2359-2364
